Orca Bio

Analyst, Data and Business Intelligence

Remote

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

Candidates must possess a Bachelor's degree in business, statistics, data science, engineering, or a related field, with at least 5 years of experience in commercial analytics, preferably within the biotech or pharmaceutical industry. Proficiency in business analytics and business intelligence tools, Excel, SQL, and data visualization best practices is essential, along with experience managing commercial data pipelines and field analytics. Familiarity with CRM configuration, master data management, and incentive compensation analytics, as well as excellent communication and collaboration skills, are also required.

Responsibilities

The Analyst, Data and Business Intelligence will build and manage the commercial data ecosystem, including ETL processes and data validation, to ensure accurate reporting. They will develop field reporting tools for call activity, onboarding progress, IC performance, and product ordering trends, while managing master data inputs and supporting business rule definition. This role involves partnering with IT and vendors for system configuration and updates, delivering monthly and ad hoc dashboards for sales, onboarding, and field engagement, and identifying key business trends to provide actionable insights. Additionally, the analyst will support commercial leadership with field activity dashboards and targeting analytics, develop and maintain commercial KPIs and performance frameworks, and track incentive compensation effectiveness. The position also requires acting as a commercial data subject matter expert, collaborating cross-functionally with various teams to align on reporting needs, supporting business planning cycles with analytic reports, and recommending improvements to commercial analytics workflows and visualization tools.

Skills

Data Analysis
Business Intelligence
Salesforce
Veeva
Power BI
Tableau
Data Warehousing
CRM Integration
ETL
Data Validation
Reporting
Forecasting
Sales Operations
Market Access

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI